A Study Conducted Over 3 Periods to Look at the Drug in the Body
NCT01225939
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
AZD8329
DRUG:
AZD8329
Sponsor
AstraZeneca